Xencor | XNCR - Ebitda

Prezzo Delle Azioni
12.13
Cambio Giornaliero
0.01 0.08%
Mensile
4.84%
Annuale
-8.11%
Q1 Previsione
11.77




Ebitda Cambiamento Data
AbbVie USD 3.52B 828M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cytokinetics USD -277.18M 169.36M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Xencor USD -51.05M 55.28M 2025-12